ロード中...
Hepatic G(i) signaling regulates whole-body glucose homeostasis
An increase in hepatic glucose production (HGP) is a key feature of type 2 diabetes. Excessive signaling through hepatic G(s)–linked glucagon receptors critically contributes to pathologically elevated HGP. Here, we tested the hypothesis that this metabolic impairment can be counteracted by enhancin...
保存先:
| 出版年: | J Clin Invest |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5785257/ https://ncbi.nlm.nih.gov/pubmed/29337301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI94505 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|